NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bio-Path Holdings Inc (NASDAQ: BPTH)

 
BPTH Technical Analysis
5
As on 30th Oct 2025 BPTH STOCK Price closed @ 0.09 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.21 & Strong Sell for SHORT-TERM with Stoploss of 0.82 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BPTHSTOCK Price

Open 0.09 Change Price %
High 0.09 1 Day 0.00 0.00
Low 0.09 1 Week -0.01 -10.00
Close 0.09 1 Month 0.03 50.00
Volume 1888 1 Year -0.68 -88.31
52 Week High 1.49 | 52 Week Low 0.05
 
NASDAQ USA Most Active Stocks
LPTX 2.05 365.91%
AMRS 0.14 100.00%
WBA 11.98 0.50%
NVDA 185.55 1.72%
WVE 18.52 147.26%
CFLT 29.87 29.08%
CETX 7.05 129.64%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
NFLX 96.79 -3.44%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
WKHS 7.59 873.08%
CTXRW 0.14 600.00%
LPTX 2.05 365.91%
NDRAW 0.03 200.00%
HCVIU 9.00 159.37%
 
NASDAQ USA Top Losers Stocks
TBIO 0.00 -100.00%
FPAY 0.01 -94.74%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
OTRK 0.07 -78.79%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
OPI 0.06 -70.00%
OPI 0.06 -70.00%
 
 
BPTH
Daily Charts
BPTH
Intraday Charts
Whats New @
Bazaartrend
BPTH
Free Analysis
 
BPTH Important Levels Intraday
RESISTANCE0.09
RESISTANCE0.09
RESISTANCE0.09
RESISTANCE0.09
RESISTANCE0.09
RESISTANCE0.09
RESISTANCE0.09
RESISTANCE0.09
 
BPTH Forecast December 2025
4th UP Forecast5.41
3rd UP Forecast3.7
2nd UP Forecast2.65
1st UP Forecast1.59
1st DOWN Forecast-1.41
2nd DOWN Forecast-2.47
3rd DOWN Forecast-3.52
4th DOWN Forecast-5.23
 
BPTH Weekly Forecast
4th UP Forecast0.69
3rd UP Forecast0.50
2nd UP Forecast0.38
1st UP Forecast0.26
1st DOWN Forecast-0.08
2nd DOWN Forecast-0.20
3rd DOWN Forecast-0.32
4th DOWN Forecast-0.51
 
BPTH Forecast2025
4th UP Forecast6.53
3rd UP Forecast4.46
2nd UP Forecast3.19
1st UP Forecast1.91
1st DOWN Forecast-1.73
2nd DOWN Forecast-3.01
3rd DOWN Forecast-4.28
4th DOWN Forecast-6.35
 
 
BPTH Other Details
Segment EQ
Market Capital 33266782.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BPTH Address
BPTH
 
BPTH Latest News
 
Your Comments and Response on Bio-Path Holdings Inc
 
BPTH Business Profile
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. The company is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas. Address: 4710 Bellaire Boulevard, Bellaire, TX, United States, 77401
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service